MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05045cam a2200589 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn882257766 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212634.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
140418s2014 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2020686037 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 019 ## - |
|---|
| -- |
900088893 |
| -- |
923675631 |
| -- |
957735429 |
| -- |
958081496 |
| -- |
963742307 |
| -- |
967764908 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781631175091 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1631175092 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1631179292 |
| Qualifying information |
hbk. |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781631179297 |
| Qualifying information |
hbk. |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
781839 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)882257766 |
| Canceled/invalid control number |
(OCoLC)900088893 |
| -- |
(OCoLC)923675631 |
| -- |
(OCoLC)957735429 |
| -- |
(OCoLC)958081496 |
| -- |
(OCoLC)963742307 |
| -- |
(OCoLC)967764908 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Subject category code subdivision |
039000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
014000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
022000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
112000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
045000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Therapy for hepatocellular carcinoma : |
| Subtitle |
etiology and treatment |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2014] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Cancer Etiology, Diagnosis and Treatments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
THERAPY FOR HEPATOCELLULARCAR CINOMA: ETIOLOGY AND TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Epidemiology and Etiology of Hepatocellular Carcinoma; Abstract; 1. Introduction; 2. Worldwide Epidemiology of HCC; 3. Epidemiology of HCC in Japan; 4. Risk Factors for HCC; 5. Future Trends in the Epidemiology of HCC; Conclusion; References; Chapter 2: Diagnosis of Hepatocellular Carcinoma Using CT and MRI; Abstract; 1. Introduction; 2. Multistep Hepatocarcinogenesis and Hemodynamics; 3. Dynamic CT Scan and Classic HCCs. |
| 505 8# - CONTENTS |
|---|
| Contents |
4. Transition in the Role of Dynamic MR Imaging in Diagnosing Classic HCCs5. Other MR Sequences Used for Diagnosing HCCs; 6. Summary of Imaging Findings of Classic HCC; 7. Macroscopic Types of HCC; 8. Assessment of Vascular Invasion of HCC by Using Multi-Planar Reconstruction of MDCT; 9. Poorly-Differentiated HCC and Special Types; 10. Hypovascular HCCs only Visualized in Hepato-Biliary Phase of EOB-MRI; 11. Hepatic Nodular Lesions that Should Be Differentiated from HCCs; Conclusion; Acknowledgment; References. |
| 505 8# - CONTENTS |
|---|
| Contents |
Chapter 3: Clinical Staging and Treatment Selection for Hepatocellular Carcinoma: Overview of the Current Status and Perspectives for the FutureAbstract; 1. Introduction; 2. Clinical Staging and Treatment Guidelines for HCC; 3. Therapeutic Strategies Based on Clinical Stage of HCC; 4. Therapeutic Approaches for HCC; 5. Multidisciplinary Management of HCC; 6. Future Perspectives; Conclusion; References; Chapter 4: Hepatic Resection for Hepatocellular Carcinoma; Abstract; 1. Introduction; 2. Preoperative Assessment (Table 1); 3. Anesthetic Techniques for Reduction of Intraoperative Blood Loss. |
| 505 8# - CONTENTS |
|---|
| Contents |
4. Surgical Procedures5. Immediate Postoperative Management; 6. Surgical Outcome; Conclusion; References; Chapter 5: Transplantation for Hepatocellular Carcinoma; Abstract; 1. Introduction; 2. Background of LT for HCC in Western Countries; 3. Background of LT for HCC in Japan; 4. Current Status of LT for HCC in Japan; 5. Current Status of LT for HCC in Western Countries; 6. Other Liver Tumors; Conclusion; References; Chapter 6: Transcatheter Arterial Chemoembolization; Abstract; 1. Introduction; 2. Rationale for TACE; 3. Devices, Equipment, Drugs, and Embolic Agents Used in TACE. |
| 505 8# - CONTENTS |
|---|
| Contents |
4. Indication and TACE Strategy5. TACE Technique; 6. Technical Variations in cTACE; 7. Periprocedural Management; 8. Outcomes; 9. Technical Tips to Improve the Therapeutic Effects of TACE; 10. TACE-Refractory HCC; 11. Complications; Conclusion; References; Chapter 7: Proton Beam Therapy for Hepatocellular Carcinoma; Abstract; 1. Introduction; 2. History of Particle Beam Therapy; 3. Principle of Facility Design; 4. Beam Delivery; 5. Method of Respiratory Control; 6. Principle of Radiation Therapy for Hepatocellular Carcinoma; 7. Treatment Results; 8. Treatment Factors for Proton Beam Therapy. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Liver |
| General subdivision |
Cancer |
| -- |
Treatment. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Ohkohchi, Nobuhiro, |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Cancer etiology, diagnosis, and treatments. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=781839">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=781839</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
11778446 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
781839 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10874546 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3024387 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |